Jemec Gregor B E, Del Marmol Véronique, Bettoli Vincenzo, Augustin Matthias, Prens Errol P, Zouboulis Christos C
Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
European Hidradenitis Suppurativa Foundation e.V, Dessau, Germany.
Exp Dermatol. 2022 Sep;31 Suppl 1:22-28. doi: 10.1111/exd.14610.
The European Hidradenitis Suppurativa Foundation (EHSF) e.V. has taken several initiatives for collaborative studies. They result from the data of the European Registry of Hidradenitis Suppurativa (ERHS) based on the knowledge obtained from the regional Northern countries (HISREG) and Italian (IRHIS) registries and the real-world data generated from claims data from insurance databases. Multicentre studies, such as the Hidradenitis Suppurativa collaborative study of subtypes (HORUS) and the Global Hidradenitis Suppurativa Atlas (GHISA), are planned to provide an ideal complement to the register studies. Most recently, the role of EHSF as a coordinator or key player is being explored in multiple genetic studies, such as a genome-wide association study (GWAS) and the exome sequencing and cellular/molecular profiling project, which will speed up gene and drug discovery in HS.
欧洲化脓性汗腺炎基金会(EHSF)已采取多项举措开展合作研究。这些举措源于欧洲化脓性汗腺炎登记处(ERHS)的数据,该数据基于从北欧国家(HISREG)和意大利(IRHIS)登记处获得的知识以及保险数据库理赔数据产生的真实世界数据。多中心研究,如化脓性汗腺炎亚型合作研究(HORUS)和全球化脓性汗腺炎图谱(GHISA),计划为登记研究提供理想补充。最近,EHSF在多项基因研究中作为协调者或关键参与者的作用正在被探索,如全基因组关联研究(GWAS)以及外显子测序和细胞/分子分析项目,这将加速化脓性汗腺炎的基因和药物发现。